Stavros G. Vizirgianakis - 15 Aug 2024 Form 4 Insider Report for Xtant Medical Holdings, Inc. (XTNT)

Role
Director
Signature
/s/ Amy E. Culbert, attorney-in-fact
Issuer symbol
XTNT
Transactions as of
15 Aug 2024
Net transactions value
$0
Form type
4
Filing time
19 Aug 2024, 17:01:54 UTC
Previous filing
12 Aug 2024
Next filing
17 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XTNT Common Stock Award $0 +243,243 +3.9% $0.000000 6,456,368 15 Aug 2024 Direct F1, F2
transaction XTNT Common Stock Award $0 +505,405 +7.8% $0.000000 6,961,773 15 Aug 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are subject to a deferred stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, and vest on August 15, 2025, conditioned upon the Reporting Person remaining a director of Xtant through the respective vesting date.
F2 Includes 966,418 shares issuable upon settlement of deferred stock units granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of Xtant through the respective vesting dates.